Hyderabad Telangana, India

Ramakrishna Pilli

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Natco Pharma Limited, Other. Active years: 2013-2020.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 8.2

ph-index = 1


Company Filing History:


Years Active: 2013-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Ramakrishna Pilli

Introduction

Ramakrishna Pilli is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer agents. With a total of two patents to his name, his work reflects a commitment to advancing medical science and improving treatment options.

Latest Patents

Ramakrishna Pilli's latest patents include a modified process for the preparation of Ceritinib and an amorphous form of Ceritinib. This invention relates to an improved process that achieves high yield and purity, making it cost-effective and feasible for large-scale production. Additionally, he has developed a stable amorphous form of Ceritinib and a process for preparing Crystalline form A of Ceritinib. His second patent involves pyrazolo[3,4-D]pyrimidine derivatives as anti-cancer agents. This invention encompasses substituted pyrazolo[3,4-d]pyrimidine derivatives that exhibit anti-proliferative activity, making them useful in treating various cancers.

Career Highlights

Throughout his career, Ramakrishna Pilli has worked with prominent companies, including Natco Pharma Limited. His experience in the pharmaceutical industry has allowed him to contribute to significant advancements in drug development and formulation.

Collaborations

Ramakrishna has collaborated with notable professionals in his field, including Durga Prasad Konakanchi and Subba Rao Pula. These collaborations have further enriched his research and development efforts.

Conclusion

Ramakrishna Pilli's innovative work in the pharmaceutical sector demonstrates his dedication to improving healthcare through scientific advancements. His patents reflect a strong commitment to developing effective treatments for cancer, showcasing his impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…